Literature DB >> 24853390

Eukaryotic elongation factor 2 kinase, an unusual enzyme with multiple roles.

Justin W Kenney1, Claire E Moore1, Xuemin Wang1, Christopher G Proud2.   

Abstract

Eukaryotic elongation factor 2 kinase (eEF2K) is a member of the small group of atypical 'α-kinases'. It phosphorylates and inhibits eukaryotic elongation factor 2, to slow down the elongation stage of protein synthesis, which normally consumes a great deal of energy and amino acids. The activity of eEF2K is normally dependent on calcium ions and calmodulin. eEF2K is also regulated by a plethora of other inputs, including inhibition by signalling downstream of anabolic signalling pathways such as the mammalian target of rapamycin complex 1. Recent data show that eEF2K helps to protect cancer cells against nutrient starvation and is also cytoprotective in other settings, including hypoxia. Growing evidence points to roles for eEF2K in neurological processes such as learning and memory and perhaps in depression.
Copyright © 2014. Published by Elsevier Ltd.

Entities:  

Keywords:  Calmodulin; Protein synthesis; eEF2; mRNA translation; mTORC1

Mesh:

Substances:

Year:  2014        PMID: 24853390     DOI: 10.1016/j.jbior.2014.04.003

Source DB:  PubMed          Journal:  Adv Biol Regul        ISSN: 2212-4926


  73 in total

Review 1.  uORF-mediated translational control: recently elucidated mechanisms and implications in cancer.

Authors:  Hung-Hsi Chen; Woan-Yuh Tarn
Journal:  RNA Biol       Date:  2019-06-24       Impact factor: 4.652

2.  Translating the anticancer properties of eEF2K.

Authors:  Aude De Gassart; Fabio Martinon
Journal:  Cell Cycle       Date:  2016-11-10       Impact factor: 4.534

Review 3.  Phosphorylation and Signal Transduction Pathways in Translational Control.

Authors:  Christopher G Proud
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-07-01       Impact factor: 10.005

4.  mTORC1 Plays an Important Role in Skeletal Development by Controlling Preosteoblast Differentiation.

Authors:  Stephen Fitter; Mary P Matthews; Sally K Martin; Jianling Xie; Soo Siang Ooi; Carl R Walkley; John D Codrington; Markus A Ruegg; Michael N Hall; Christopher G Proud; Stan Gronthos; Andrew C W Zannettino
Journal:  Mol Cell Biol       Date:  2017-03-17       Impact factor: 4.272

5.  Solution Structure of the Carboxy-Terminal Tandem Repeat Domain of Eukaryotic Elongation Factor 2 Kinase and Its Role in Substrate Recognition.

Authors:  Andrea Piserchio; Nathan Will; David H Giles; Fatlum Hajredini; Kevin N Dalby; Ranajeet Ghose
Journal:  J Mol Biol       Date:  2019-05-18       Impact factor: 5.469

6.  Glucagon-like peptide-1 cleavage product GLP-1 (9-36) amide enhances hippocampal long-term synaptic plasticity in correlation with suppression of Kv4.2 expression and eEF2 phosphorylation.

Authors:  Stephen M Day; Wenzhong Yang; Sarah Ewin; Xueyan Zhou; Tao Ma
Journal:  Hippocampus       Date:  2017-08-30       Impact factor: 3.899

7.  Acute alcohol prevents the refeeding-induced decrease in autophagy but does not alter the increased protein synthetic response in heart.

Authors:  Marina Mekheal; Jennifer L Steiner; Charles H Lang
Journal:  Alcohol       Date:  2018-04-18       Impact factor: 2.405

Review 8.  eIF2α phosphorylation and the regulation of translation.

Authors:  Erik Boye; Beáta Grallert
Journal:  Curr Genet       Date:  2019-09-04       Impact factor: 3.886

9.  Structure of the C-Terminal Helical Repeat Domain of Eukaryotic Elongation Factor 2 Kinase.

Authors:  Nathan Will; Andrea Piserchio; Isaac Snyder; Scarlet B Ferguson; David H Giles; Kevin N Dalby; Ranajeet Ghose
Journal:  Biochemistry       Date:  2016-09-14       Impact factor: 3.162

10.  eEF-2 kinase is a critical regulator of Warburg effect through controlling PP2A-A synthesis.

Authors:  Y Cheng; X Ren; Y Yuan; Y Shan; L Li; X Chen; L Zhang; Y Takahashi; J W Yang; B Han; J Liao; Y Li; H Harvey; A Ryazanov; G P Robertson; G Wan; D Liu; A F Chen; Y Tao; J-M Yang
Journal:  Oncogene       Date:  2016-05-16       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.